SIRT1 and type 2 diabetes mellitus: Astragaloside IV, an active ingredient of Astragalus propinquus, increases the level of butyric acid in gut microbiota of T2DM mice and exerts therapeutic effects on T2DM by regulating AMPK/SIRT1 and PI3K/AKT signaling pathways (8).